Drew Sycoff - Jul 1, 2024 Form 4 Insider Report for GlucoTrack, Inc. (GCTK)

Role: Director, 10%+ Owner
Signature: /s/ Andrew Sycoff, By Kathryn Simons through Power of Attorney
Stock symbol: GCTK
Transactions as of: Jul 1, 2024
Transactions value $: $0
Form type: 4
Date filed: 7/3/2024, 05:39 PM
Previous filing: Apr 24, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GCTK	Warrants to Purchase Common Stock	Purchase		+138K			138K	Jul 1, 2024	Common Stock	138K	$4.95	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 1, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired warrants to purchase 138,000 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock") for an aggregate purchase price of $46,000. Each warrant entitles the holder thereof to purchase one share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $4.95 per share, and expires five years after issuance.

Content

On July 1, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired warrants to purchase 138,000 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock") for an aggregate purchase price of $46,000. Each warrant entitles the holder thereof to purchase one share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $4.95 per share, and expires five years after issuance.